¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"anti"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • antiepileptic
    1. Ç×°£Áú- 2. °£Áú¾à, Ç×°£ÁúÁ¦
  • antiestrogen
    1. Ç׿¡½ºÆ®·Î°Õ- 2. Ç׿¡½ºÆ®·Î°ÕÁ¦
  • antifibrillatory
    1. Àܶ³¸²Á¦°Å-, Ç×¼¼µ¿- 2. Àܶ³¸²Á¦°ÅÁ¦, Ç×¼¼µ¿Á¦
  • antifibrinolysin
    Ç×¼¶À¯¼Ò¿ëÇØ¼ÒÁ¦
  • antifibrinolytic
    1. Ç×¼¶À¯¼Ò¿ëÇØ-, Ç×ÇǺ기¿ëÇØ- 2. Ç×¼¶À¯¼Ò¿ëÇØÁ¦, Ç×ÇǺ기¿ëÇØÁ¦
  • antifibrotic
    1. Ç×¼¶À¯Áõ-, Ç×¼¶À¯È­- 2. Ç×¼¶À¯È­Á¦
  • antifoaming agent
    Ç×±âÆ÷Á¦, ±âÆ÷Á¦°ÅÁ¦
  • antifreeze protein
    Ç×µ¿°á´Ü¹éÁú
  • antifriction material
    ¸¶Âû°¨¼ÒÀç
  • antifungal
    1. Ç×°õÆÎÀÌ-, Ç×Áø±Õ- 2. Ç×Áø±ÕÁ¦
  • antifungal action
    Ç×Áø±ÕÀÛ¿ë
  • antifungal agent
    Ç×Áø±ÕÁ¦
  • antifungal substance
    Ç×Áø±Õ¹°Áú
  • antigalactic
    1. Á¥ºÐºñ¾ïÁ¦- 2. Á¥ºÐºñ¾ïÁ¦Á¦
  • antigen
    Ç׿ø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • antifungal agent
    Ç×Áø±ÕÁ¦
  • antifungal substance
    Ç×Áø±Õ¹°Áú
  • antigen
    Ç׿ø
  • antigen analysis
    Ç׿øºÐ¼®
  • antigen binding capacity
    Ç׿ø°áÇÕ´É
  • antigen binding fragment
    Ç׿ø°áÇÕºÎÀ§
  • antigen binding receptor
    Ç׿ø°áÇÕ¼ö¿ëü
  • antigen capture assay
    Ç׿øÆ÷È¹ÃøÁ¤
  • antigen competition
    Ç׿ø°æÀï
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö
  • antigen excess
    Ç׿ø°úÀ×
  • antigen excess zone
    Ç׿ø°úÀ×±¸¿ª
  • antigen mimicry
    Ç׿øÀ¯»ç¼º
  • antigen modification
    Ç׿øº¯È­, Ç׿ø¼ö½Ä
  • antigen presentation
    Ç׿øÀü´Þ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • antibody formation
    Ç×üÇü¼º(ù÷ô÷û¡à÷).
  • antibody forming cell
    Ç×ü»ý»ê¼¼Æ÷(ù÷ô÷ßæß§á¬øà).
  • antibody half-life
    Ç×ü¹Ý°¨±â(ù÷ô÷ÚâÊïÑ¢).
  • antibody identification test
    Ç×üȮÀΰ˻ç
  • antibody producing cell
    Ç×ü»ý»ê¼¼Æ÷
  • antibody production
    Ç×ü»ý»ê(¡­ßæß§).
  • antibody removal
    Ç×üÁ¦°Å
  • antibody response
    Ç×ü¹ÝÀÀ(¡­Úãëë).
  • antibody screening cells
    Ç×ü¼±º°Ç÷±¸
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • antibody structure
    Ç×ü±¸Á¶(¡­Ï°ðã).
  • antibody synthesis =a. production
    Ç×ü»ý»ê, Ç×üÇÕ¼º.
  • antibody titer
    Ç×ü°¡(ù÷ô÷ʤ).
  • antibody to HBc ag
    B Çü °£¿°ÇÙ½ÉÇ׿ø¿¡´ëÇÑ Ç×ü
  • antibody to HBe ag
    B Çü °£¿°¿ÜÇÇÇ׿ø¿¡´ëÇÑ Ç×ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • antibody formation
    Ç×üÇü¼º(ù÷ô÷û¡à÷).
  • antibody forming cell
    Ç×ü»ý»ê¼¼Æ÷(ù÷ô÷ßæß§á¬øà).
  • antibody half-life
    Ç×ü¹Ý°¨±â(ù÷ô÷ÚâÊïÑ¢).
  • antibody identification test
    Ç×üȮÀΰ˻ç
  • antibody producing cell
    Ç×ü»ý»ê¼¼Æ÷
  • antibody production
    Ç×ü»ý»ê(¡­ßæß§).
  • antibody removal
    Ç×üÁ¦°Å
  • antibody response
    Ç×ü¹ÝÀÀ(¡­Úãëë).
  • antibody screening cells
    Ç×ü¼±º°Ç÷±¸
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • antibody structure
    Ç×ü±¸Á¶(¡­Ï°ðã).
  • antibody synthesis =a. production
    Ç×ü»ý»ê, Ç×üÇÕ¼º.
  • antibody titer
    Ç×ü°¡(ù÷ô÷ʤ).
  • antibody to HBc ag
    B Çü °£¿°ÇÙ½ÉÇ׿ø¿¡´ëÇÑ Ç×ü
  • antibody to HBe ag
    B Çü °£¿°¿ÜÇÇÇ׿ø¿¡´ëÇÑ Ç×ü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • antipellagra factor
    Ç×(ù÷)Æç¶ó±×¶ó ÀÎÀÚ(ì×í­)
  • antipeptic ulcer factor
    Ç×(ù÷)±Ë¾ç(Ï÷åË) ÀÎÀÚ(ì×í­)
  • antipernicious anemia factor
    Ç×(ù÷)¾Ç¼ººóÇ÷(äÂàõÞ¸úì) ÀÎÀÚ(ì×í­)
  • antipod
    ´ëÀåü(Óßíæô÷)
  • antipolarity
    ¿ª±Ø¼º(æ½Ð¿àõ)
  • antiport
    ¿ª¼ö¼Û(æ½âÃáê)
  • antipromoter
    Ç×(ù÷)ÇÁ·Î¸ðÅÍ
  • antipurine
    Ç×(ù÷)Ç»¸°
  • antipyrimidine
    Ç×(ù÷)ÇǸ®¹Ìµò
  • antirachitic vitamin
    Ç×±¸·çº´(ù÷±¸·çÜ») ºñŸ¹Î
  • antirepressor
    Ç×¾ïÁ¦ÀÚ(ù÷åäð¤í­)
  • antiscorbutic factor
    Ç×±«Ç÷º´ÀÎÀÚ(ù÷ÎÕúìÜ»ì×í­)
  • antisense strand
    ¾ÈƼ¼¾½º °¡´Ú
  • antisepsis
    ¹æºÎ(ÛÁݯ)
  • antiserum
    Ç×Ç÷û(ù÷úìôè)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
AIRA anti-insulin receptor antibody
AIS Abbreviated Injury Scale; amniotic infection syndrome; androgen insensitivity syndrome; anterior int...
AMH Accreditation Manual for Hospitals; anti-mullerian hormone; automated medical history
APHP anti-Pseudomonas human plasma
ASTA anti-alpha-staphylolysin
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
GalC Anti-galactocerebroside
AGA Anti-gliadin
AGA Anti-gliadin antibodies
AGA Anti-gliadin antibody
GFAP Anti-glial fibrillary acidic protein
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Y56.1
    Antipruritics
    °¡·Á¿ò¾à(Ç×°¡·Á¿òÁ¦)
  • Y45.4
    Antirheumatics
    Ç×·ù¸¶Æ¼½ºÁ¦
  • T39.4
    Antirheumatics, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº Ç×·ù¸¶Æ¼½ºÁ¦
  • Y46.8
    Antispasticity drugs
    Ç×°æ·Ã¼º ¾à¹°
  • Y44.4
    Antithrombotic drugs [platelet-aggregation inhibitors]
    Ç×Ç÷ÀüÁ¦[Ç÷¼ÒÆÇ ÀÀÁý ¾ïÁ¦Á¦]
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antigen processing
    Ç׿ø ó¸®
    Ç׿øÀÌ Ç׿ø Á¦½Ã ¼¼Æ÷¿¡ ÀÇÇÏ¿© Æ÷ÃËµÇ°í ³ª¼­ B ¼¼Æ÷, T ¼¼Æ÷¿¡ Ç׿øÀÌ Á¦½ÃµÇ±â±îÁöÀÇ °úÁ¤À» ¸»ÇÑ´Ù. ÀÌ °úÁ¤¿¡´Â Ç׿øÀÇ Å½½Ä, Ç׿øÀÇ ´ÜÆíÈ­ ȤÀº Ç׿ø °áÁ¤±â±îÁöÀÇ ºÐÇØ 󸮰¡ Æ÷ÇԵȴÙ.
  • antigen receptor
    Ç׿ø ¼ö¿ëü
  • antigen recognition site
    Ç׿ø ½Äº°ºÎ
  • antigen shift
    Ç׿ø ´ëº¯ÀÌ
  • antigen unit
    Ç׿ø ´ÜÀ§
  • antigen-antibody reaction
    Ç׿ø-Ç×ü ¹ÝÀÀ
  • antigenic assay
    Ç׿ø¼º ºÐ¼®
  • antigenic specificity
    Ç׿ø ƯÀ̼º
  • antigenic suicide
    Ç׿ø¿¡ ÀÇÇÑ ¸²ÇÁ±¸ÀÇ ÀÚ¸ê
    °íµµ·Î ¹æ»ç Ȱ¼ºÀÌ ÀÖ´Â Ç׿øÀ» »ýü¿¡ Åõ¿©Çϸé ÀÌ Ç׿ø¿¡ ´ëÇÏ¿© °¨¼ö¼ºÀÌ ÀÖ´Â ¸²ÇÁ±¸´Â °¨¼Ò ³»Áö ºÒȰ¼ºÈ­µÇ¾î ¹ö¸°´Ù. µû¶ó¼­ ¹æ»ç Ȱ¼ºÀÌ ¾ø´Â °°Àº Ç׿øÀ» Åõ¿©Çصµ ÀÌ Ç׿ø¿¡ ƯÀÌÀûÀÎ ¸é¿ª ÀÀ´äÀº »ý±âÁö ¾Ê°Ô µÈ´Ù. À̰ÍÀº Ç׿ø¿¡ ¹ÝÀÀÇÏ´Â ¸²ÇÁ±¸°¡ ¹æ»ç Ȱ¼ºÀÌ ÀÖ´Â Ç׿øÀ» °áÇÕ½ÃÅ´À¸·Î½á ¹æ»ç´É¿¡ ÀÇÇÑ ¼¼Æ÷ ¼Õ»óÀ» ÀԾ ¾ß±âµÇ´Â °ÍÀÌ´Ù. À̰ÍÀ» Ç׿ø¿¡ ÀÇÇÑ ¸²ÇÁ±¸ÀÇ ÀÚ¸êÀ̶ó°í ÇÑ´Ù.
  • antigenicity
    ¹ÝÀÀ¿ø¼º, Ç׿ø¼º
    1. ¾î¶² Ç׿øÀÌ ±× ¹°Áú¿¡ ´ëÇÑ Æ¯ÀÌ ¸é¿ª ÀÀ´ä »ê¹°ÀÎ Ç×ü¿Í °áÇÕÇϰųª, °¨ÀÛµÈ T ¼¼Æ÷¿Í ¹ÝÀÀÇÏ´Â ¼ºÁúÀ» ¸»ÇÑ´Ù. 2. ¾î¶² ¹°ÁúÀ» »ýü¿¡ Åõ¿©ÇßÀ» ¶§ ¸é¿ª¹ÝÀÀÀ» ÀÏÀ¸Å°´Â ´É·ÂÀ» Ç׿ø¼ºÀ̶ó°í ÇÑ´Ù. ¶Ç ¾î¶² ¹°ÁúÀÌ Ç×ü¿Í °áÇÕÇÏ´Â ´É·ÂÀ» ¹ÝÀÀ¿ø¼ºÀ̶ó°í ÇÑ´Ù. ¸é¿ª¿ø¼º, ¹ÝÀÀ¿ø¼ºÀÇ ¾çÂÊÀÇ ¼º°ÝÀ» Ç׿ø¼ºÀ̶ó°í ÇÑ´Ù. ÇÕÅÙ µîÀÇ ºÐÀÚ´Â ¹ÝÀÀ¿ø¼ºÀ» °¡Áö°í ÀÖÁö¸¸ ±×°Í ÀÚü¿¡´Â ¸é¿ª¿ø¼ºÀÌ ¾ø´Ù. ±×·¯³ª ¸é¿ª¿ø¼ºÀ» °¡Áö°í ÀÖ´Â ´Ü¹é ºÐÀÚ¿¡ ÇÕÅÙÀ» °áÇÕ½Ã۸é ÀÌ ´ãüÀ§ÀÇ ÇÕÅÙÀº ¸é¿ª¿ø¼ºÀ» ȹµæÇÑ´Ù.
  • antiglobulin antibody
    Çױ۷κθ° Ç×ü
  • antiglobulin test
    Çױ۷κθ° °Ë»ç, Çױ۷κθ° ½ÃÇè
    ºÒ¿ÏÀü Ç×ü°¡ ÀûÇ÷±¸¿Í °áÇÕÇϸ鼭 ºñÀÀÁý¼ºÀÎ °æ¿ì, ŸÁ¾ µ¿¹°¿¡¼­ ÀÛ¼ºÇÑ Ç× IgG Ç×ü¸¦ Ãß°¡ÇÔÀ¸·Î½á ´Ù¸®°¡ ³õ¾ÆÁ® ÀÀÁý¹ÝÀÀÀÌ ¹ß»ýÇÑ´Ù. 1945³â Coombs¿¡ ÀÇÇÏ¿© Àç¹ß°ßµÈ ¹æ¹ýÀÌ¸ç »ýü ³»¿¡¼­ ÀÌ¹Ì ÀûÇ÷±¸¿Í °áÇÕÇϰí ÀÖ´Â Ç×ü¸¦ °ËÃâÇÏ´Â Á÷Á¢ ½ÃÇè°ú À¯¸®ÇØ ÀÖ´Â Ç×ü¸¦ ÀûÇ÷±¸¿Í °áÇÕ½ÃŰ°í ³ª¼­ °ËÃâÇÏ´Â °£Á¢ ½ÃÇèÀÌ ÀÖ´Ù.
  • antigonadotropin
    Ç×°í³ªµµÆ®·ÎÇÉ
  • antihallucinogen
    Ç×ȯ°¢Á¦
  • antihemicranin
    ÆíµÎÅë Ä¡·áÁ¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
antibiotics, peptide Antibiotics whose structure contains one or more peptides, usually cyclic. They are generally effective against gram-positive bacteria and act by inhibiting peptidoglycan synthesis in bacterial cell walls.
(12 Dec 1998)
antibiotics, tetracycline <chemical> Broad-spectrum natural and semisynthetic antibiotics with a naphthacene structure obtained from various streptomyces species.
Pharmacological action: protein synthesis inhibitor.
(12 Dec 1998)
antibiotin <protein> Biotin binding protein (68 kD) from egg white. Binding is so strong as to be effectively irreversible a diet of raw egg white leads to biotin deficiency.
(18 Nov 1997)
antiblennorrhagic Rarely used term for:1. Preventive or curative of a mucous discharge (blennorrhagia).
2. A remedy possessing such properties.
(05 Mar 2000)
antibodies Any of numerous protein molecules produced by the B-cells as a primary immune defense.
(16 Dec 1997)
antibodies, anti-idiotypic Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.
(12 Dec 1998)
antibodies, anticardiolipin Antiphospholipid antibodies found in association with systemic lupus erythematosus (lupus erythematosus, systemic), antiphospholipid syndrome, and in a variety of other diseases as well as in healthy individuals. The antibodies are detected by solid-phase immunoassay employing the purified phospholipid antigen cardiolipin.
(12 Dec 1998)
antibodies, antineutrophil cytoplasmic Autoantibodies directed against cytoplasmic constituents of polymorphonuclear leukocytes and/or monocytes. They are used as specific markers for wegener's granulomatosis and other diseases, though their pathophysiological role is not clear. Anca are routinely detected by indirect immunofluorescence with three different patterns: c-anca (cytoplasmic), p-anca (perinuclear), and atypical anca.
(12 Dec 1998)
antibodies, antinuclear See: Antinuclear antibodies.
(12 Dec 1998)
antibodies, antiphospholipid Autoantibodies directed against phospholipids. These antibodies are characteristically found in patients with systemic lupus erythematosus (lupus erythematosus, systemic), antiphospholipid syndrome, related autoimmune diseases, some non-autoimmune diseases, and also in healthy individuals.
(12 Dec 1998)
antibodies, archaeal Immunoglobulins induced by substances elaborated by archaea that have an antigenic activity.
(12 Dec 1998)
antibodies, bacterial Immunoglobulins induced by substances elaborated by bacteria that have an antigenic activity.
(12 Dec 1998)
antibodies, bispecific Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate antigenic determinants. They are artificial antibodies produced by chemical crosslinking, fusion of hybridoma cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabelled haptens, and effector cells to diseased tissue, primarily tumours.
(12 Dec 1998)
antibodies, blocking Antibodies that inhibit the reaction between antigen and other antibodies or sensitised T-lymphocytes (e.g., antibodies of the IgG class that compete with IgE antibodies for antigen, thereby blocking an allergic response). Blocking antibodies that bind tumours and prevent destruction of tumour cells by cytotoxic T-lymphocytes have also been called enhancing antibodies.
(12 Dec 1998)
antibodies, catalytic Antibodies that can catalyze a wide variety of chemical reactions. They are characterised by high substrate specificity and share many mechanistic features with enzymes.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 8
  • Antibodies, Heterophile - »õâ Antibodies elicited in a different species from which the antigen originated. These antibodies are directed against a wide variety of interspecies-specific antigens, the best known of which are Forssman, Hanganutziu-Deicher (H-D), and Paul-Bunnell (P-B). Incidence of antibodies to these antigens--i.e., the phenomenon of heterophile antibody response--is useful in the serodiagnosis, pathogenesis, and prognosis of infection and latent infectious states as well as in cancer classification.
    Synonyms : Antibodies, Heterologous, Antibodies, Heterophil, Antibodies, Xenogenic, Forssman Antibody, Heterogenetic Antibodies, Antibody, Forssman, Heterophil Antibodies, Heterotypic Antibodies, Xenogeneic Antibodies, Xenogenic Antibodies
  • Antibodies, Monoclonal - »õâ Antibodies produced by clones of cells such as those isolated after hybridization of activated B LYMPHOCYTES with neoplastic cells. These hybrids are often referred to as HYBRIDOMAS.
    Synonyms :
  • Antibodies, Neoplasm - »õâ Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS.
    Synonyms : Antibodies, Tumor
  • Antibodies, Phospho-Specific - »õâ Antibodies directed against immunogen-coupled phosphorylated PEPTIDES corresponding to amino acids surrounding the PHOSPHORYLATION site. They are used to study proteins involved in SIGNAL TRANSDUCTION pathways. (From Methods Mol Biol 2000; 99:177-89)
    Synonyms : Phosphospecific Antibody, Antibodies, Antiphosphopeptide Specific, Antibodies, Phospho Specific, Antibodies, Phosphopeptide Specific, Antibodies, Phosphorylation State-Specific, Antibody, Phosphospecific, Antiphosphopeptide-Specific Antibodies
  • Antibodies, Protozoan - »õâ Antibodies produced by human or animal cells following clinical or experimental exposure to parasitic PROTOZOAN ANTIGENS.
    Synonyms :
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 10 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
antiviral any drug that destroys viruses inhibiting or stopping the growth and reproduction of viruses
Ãâó: wordnet.princeton.edu/perl/webwn
antidiuretic a drug that limits the formation of urine
Ãâó: wordnet.princeton.edu/perl/webwn
antidiuretic hormone vasopressin: hormone secreted by the posterior pituitary gland (trade name Pitressin) and also by nerve endings in the hypothalamus; affects blood pressure by stimulating capillary muscles and reduces urine flow by affecting reabsorption of water by kidney tubules
Ãâó: wordnet.princeton.edu/perl/webwn
antidotal counteracting the effects of a poison
Ãâó: wordnet.princeton.edu/perl/webwn
antidote a remedy that stops or controls the effects of a poison
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • antihuman
    Àΰ£¿¡ ¹ÝÇ×ÇÏ´Â;Ç×ÀÎÀÇ
  • antiicer
    ¹æºùÀåÄ¡
  • antiimperialism
    ¹ÝÁ¦±¹ÁÖÀÇ
  • antiinflammatoru
    ¿°Áõ¿¡ È¿ÇèÀÌ ÀÖ´Â;Ç׿°ÁõÀÇ;Ç׿°Áõ¾à
  • antiintellectualism
    ¹ÝÁö¼ºÁÖÀÇ;Áö½ÄÀÎ ºÒ½Å
  • antiknock
    ¾ÈƼ³ì;Æø¿¬ ÀåÁöÁ¦
  • antileukemic
    Ç×¹éÇ÷º´ÀÇ;¹éÇ÷±¸ÀÇ Áõ°¡¸¦ ¾ïÁ¦ÇÏ´Â
  • antilitter
    ¾²·¹±â ¹ö¸®±â¸¦ ±ÝÇÏ´Â
  • antilles
    ¾ØÆ¿¸®ÀÌÁî ¿­µµ
  • antilogy
    ÀÚ°¡ ´çÂø;ÀüÈÄ ¸ð¼ø
  • antimacassar
    ÀÇÀÚµ¤°³
  • antimagnetic
    (½Ã°è µî)Ç×ÀÚ¼ºÀÇ;Àڱ⠺Ұ¨ÀÇ;ÀÚÈ­ ¹æÁöÀÇ
  • antimalarial
    ¸»¶ó¸®¾Æ ¿¹¹æÀÇ;¸»¶ó¸®¾Æ¿¡ µè´Â;¸»¶ó¸®¾Æ ¿¹¹æ¾à
  • antiMarketeer
    ¿µ±¹ÀÇ EC°¡¸Í¿¡ ¹Ý´ëÇÏ´Â »ç¶÷
  • antimask
    ÀÍ»ì Ã̱Ø
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 8
anti of or relating to an anticoagulant
anti a drug used to treat or prevent convulsions (as in epilepsy)
anti a drug used to treat or prevent convulsions (as in epilepsy)
anti (meteorology) winds spiraling outward from a high-pressure center
anti (meteorology) of or relating to or characteristic of the atmosphere around a high pressure center
anti any of a class of drugs used to treat depression
anti any of a class of drugs used to treat depression
anti a drug used to treat diabetes mellitus
anti a drug used to treat diabetes mellitus
anti a drug used to control or stop diarrhea
anti a drug used to control or stop diarrhea
anti a drug that limits the formation of urine
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 8
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á